跳至主要内容
临床试验/DRKS00004646
DRKS00004646已完成不适用

ong-term sequelae after septic multi-organ failure - a pilot study on immunological, neuroendocrine and metabolic changes in post-acute-care hospital

Integriertes Forschungs- und BehandlungszentrumCenter of Sepsis Control and CarePaul-Martini-Forschergruppe ”Clinical Septomics”0 个研究点目标入组 24 人开始时间: 2013年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

The present findings reveal that CCI sepsis patients feature signs of immune suppression but that their T cells exhibit a primed, rather than a suppressed, phenotype in their TCR response, arguing against a generalized T cell paralysis as a major cause of protracted immune suppression from sepsis.

研究设计

研究类型
Observational

入排标准

年龄范围
55 Years 至 80 Years(—)
性别
Male

入选标准

  • 1. Male patients, age 55-80 years
  • 2. State after SIRS / sepsis with multiple organ failure in the pre-treating acute hospital
  • 3. Presence of critical illness polyneuropathy and myopathy (CIPNP and CIMP)
  • 4. Chronic critical illness with 2-organ failure:
  • - Prolonged mechanical ventilation > 3 weeks and < 12 weeks
  • - state after acute renal failure and currently running renal replacement therapy

排除标准

  • 1. Previous chemotherapy or radiation therapy
  • 2. C-reactive protein mg> 140 / L
  • 3. Chronic immunosuppression
  • 4. Treatment with Prednisolone within the last 8 days before taking blood samples
  • 5. Current septic inflammation
  • 6. Chronic renal failure with ambulant dialysis
  • 7. Current therapy with vasopressors
  • 8. Acute Lung Injury (ALI): FiO2> 30%
  • 9. Traumatic Brain Injury
  • 10. Intracerebral hemorrhage / stroke within the last 12 weeks

研究者

发起方
Integriertes Forschungs- und BehandlungszentrumCenter of Sepsis Control and CarePaul-Martini-Forschergruppe ”Clinical Septomics”

相似试验